← Mechanisms of action
MUC16
SINGLE PROTEINHomo sapiens
Preferred name: Mucin-16 ChEMBL ↗
Linked proteins
Drugs acting on this target (15)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| BW 494 | Adcc | experimental | mAb | CA125 |
| OC125 | Adcc | experimental | mAb | MUC16 |
| igovomab | Binding agent | experimental | mAb | MUC16 binding agent |
| sofituzumab vedotin | Binding agent | experimental | mAb | MUC16 binding agent |
| lbl-033 | Immunity, active | experimental | mAb | MUC16 immunity, active |
| Abagovomab | Immunity, passive | experimental | mAb | MUC16 immunity, passive |
| gb-5267 | Immunity, passive | experimental | Cell therapy | MUC16 immunity, passive |
| prgn-3005 | Immunity, passive | experimental | Cell therapy | MUC16 immunity, passive |
| dmuc4064a | Inhibitor | experimental | mAb | MUC16 inhibitor |
| igovomab | Inhibitor | experimental | mAb | MUC16 inhibitor |
| regn4018 | Inhibitor | experimental | mAb | MUC16 inhibitor |
| regn5668 | Inhibitor | experimental | mAb | MUC16 inhibitor |
| sofituzumab vedotin | Inhibitor | experimental | mAb | MUC16 inhibitor |
| Abagovomab | Other | experimental | mAb | MUC16 other |
| oregovomab | Other | experimental | mAb | MUC16 other |